- Home
- HCWB vs PETZ Comparison
HCWB vs PETZ Comparison
Compare HCWB & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- PETZ
- Stock Information
- Founded
- HCWB 2018
- PETZ 2002
- Country
- HCWB United States
- PETZ China
- Employees
- HCWB N/A
- PETZ N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- PETZ Steel/Iron Ore
- Sector
- HCWB Health Care
- PETZ Industrials
- Exchange
- HCWB Nasdaq
- PETZ Nasdaq
- Market Cap
- HCWB 10.8M
- PETZ 9.3M
- IPO Year
- HCWB 2021
- PETZ 2017
- Fundamental
- Price
- HCWB $3.45
- PETZ $1.01
- Analyst Decision
- HCWB Strong Buy
- PETZ
- Analyst Count
- HCWB 1
- PETZ 0
- Target Price
- HCWB $35.00
- PETZ N/A
- AVG Volume (30 Days)
- HCWB 30.0K
- PETZ 5.7K
- Earning Date
- HCWB 08-18-2025
- PETZ 04-28-2025
- Dividend Yield
- HCWB N/A
- PETZ N/A
- EPS Growth
- HCWB N/A
- PETZ N/A
- EPS
- HCWB N/A
- PETZ 0.26
- Revenue
- HCWB $832,841.00
- PETZ $563,726.00
- Revenue This Year
- HCWB $178.36
- PETZ N/A
- Revenue Next Year
- HCWB N/A
- PETZ N/A
- P/E Ratio
- HCWB N/A
- PETZ $4.82
- Revenue Growth
- HCWB N/A
- PETZ 74664.72
- 52 Week Low
- HCWB $2.77
- PETZ $0.65
- 52 Week High
- HCWB $100.80
- PETZ $1.74
- Technical
- Relative Strength Index (RSI)
- HCWB 31.06
- PETZ 50.05
- Support Level
- HCWB $2.77
- PETZ $0.98
- Resistance Level
- HCWB $4.65
- PETZ $1.04
- Average True Range (ATR)
- HCWB 0.36
- PETZ 0.06
- MACD
- HCWB -0.09
- PETZ -0.00
- Stochastic Oscillator
- HCWB 36.22
- PETZ 38.73
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.